➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Express Scripts
Boehringer Ingelheim
Johnson and Johnson
Medtronic
Dow
Baxter

Last Updated: July 12, 2020

DrugPatentWatch Database Preview

Litigation Details for Apotex Inc v. Daiichi Sankyo, Inc. (N.D. Ill. 2015)


Email this page to a colleague

» See Plans and Pricing

« Back to Dashboard

Small Molecule Drugs cited in Apotex Inc v. Daiichi Sankyo, Inc.
The small molecule drugs covered by the patent cited in this case are   Start Trial and   Start Trial .

Details for Apotex Inc v. Daiichi Sankyo, Inc. (N.D. Ill. 2015)

Date Filed Document No. Description Snippet Link To Document
2015-04-27 1 -infringement of United States Patent No. 6,878,703 (“the ’703 patent”) to enable Apotex to bring its…the expiration of United States Patent No. 5,616,599 (“the ’599 patent”) and any applicable pediatric … PATENT IN SUIT 15. On its face the ’703 patent entitled “Pharmaceutical…United States Patent and Trademark Office on April 12, 2005. A copy of the ’703 patent is attached as…States Patent and Trademark Office, Sankyo Company, Limited is the assignee of the ’703 patent. External link to document
2016-01-08 66 United States Patents Nos. 6,878,703 (the “703 patent”) and 5,616,599 (the “599 patent”) with the FDA…1) no patent information has been filed with the FDA, (2) the patent has expired, (3) the patent will …infringed the ‘599 patent, and Mylan’s Paragraph IV certifications for that patent were thus converted…ANDA infringed on a patent, and that it should not be considered until that patent expired). Mylan’s ANDAs…Paragraph IV certifications as to the ‘703 patent because that patent, although disclaimed, remains listed External link to document
>Date Filed >Document No. >Description >Snippet >Link To Document

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Moodys
McKesson
Boehringer Ingelheim
Express Scripts
Mallinckrodt
Colorcon

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.